Targeting CD38 with Daratumumab Suppresses B-Cell Receptor Signaling and Enhances the Activity of Ibrutinib in Waldenstrom Macroglobulinemia Cells

被引：0
|
作者：
Paulus, Aneel
Manna, Alak
Akhtar, Sharoon
Sher, Taimur
Roy, Vivek
Coleman, Morton
Novak, Anne J.
Ansell, Stephen M.
Malavasi, Fabio
Ailawadhi, Sikander
Chanan-Khan, Asher A.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1529
引用
收藏
页数：2
相关论文
共 50 条
  • [31] CLONING OF A NOVEL B-CELL ACTIVATION ANTIGEN RELATED TO HUMAN CD38
    SANTOSARGUMEDO, L
    HARADA, N
    CHANG, R
    HEATH, AW
    GRIMALDI, C
    PARKHOUSE, RME
    HOWARD, M
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 169 - 169
  • [32] CD38 expression does not change in B-cell chronic lymphocytic leukemia
    D'Arena, G
    Nunziata, G
    Coppola, G
    Vigilotti, ML
    Tartarone, A
    Carpinelli, N
    Matera, R
    Bisogno, RC
    Pistolese, G
    Di Renzo, N
    BLOOD, 2002, 100 (08) : 3052 - 3053
  • [33] CD38 as a reliable marker of post-transplant B-cell lymphomas
    Lemoine, A
    Azoulay, D
    Saliba, F
    Emile, JF
    Samuel, D
    Debuire, B
    TRANSPLANTATION, 2001, 71 (01) : S3 - S3
  • [34] Soluble CD38 significantly prolongs the lifespan of memory B-cell responses
    Liu, Xue Q.
    Hart, Derek N. J.
    MacPherson, Gordon G.
    Good, Michael F.
    Wykes, Michelle N.
    IMMUNOLOGY, 2008, 125 (01) : 14 - 20
  • [35] Therapeutic Targeting of B-Cell Receptor Signaling Pathways
    Byrd, John C.
    BLOOD, 2012, 120 (21)
  • [36] Targeting B-cell receptor signaling: changing the paradigm
    Fowler, Nathan
    Davis, Eric
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2013, : 553 - 560
  • [37] CD38 CD49d Are Physically and Functionally Associated in B-Cell Chronic Lymphocytic Leukemia Cells
    Zucchetto, Antonella
    Vaisitti, Tiziana
    Benedetti, Dania
    Bomben, Riccardo
    Dal-Bo, Michele
    Degan, Massimo
    Del Poeta, Giovanni
    Gattei, Valter
    Malavasi, Fabio
    Deaglio, Silvia
    BLOOD, 2009, 114 (22) : 151 - 151
  • [38] Human CD38 regulates B cell antigen receptor dynamic organization in normal and malignant B cells
    Camponeschi, Alessandro
    Klasener, Kathrin
    Sundell, Timothy
    Lundqvist, Christina
    Manna, Paul T.
    Ayoubzadeh, Negar
    Sundqvist, Martina
    Thorarinsdottir, Katrin
    Gatto, Mariele
    Visentini, Marcella
    Onnheim, Karin
    Aranburu, Alaitz
    Forsman, Huamei
    Ekwall, Olov
    Fogelstrand, Linda
    Gjertsson, Inger
    Reth, Michael
    Martensson, Inga-Lill
    JOURNAL OF EXPERIMENTAL MEDICINE, 2022, 219 (09):
  • [39] Deletion of CD38 enhances CD19 chimeric antigen receptor T cell function
    Veliz, Kimberly
    Shen, Feng
    Shestova, Olga
    Shestov, Maksim
    Shestov, Alexander
    Sleiman, Sara
    Hansen, Tyler
    O'Connor, Roddy S.
    Gill, Saar
    MOLECULAR THERAPY ONCOLOGY, 2024, 32 (02):
  • [40] Targeting B-Cell Receptor Signaling for Anticancer Therapy: The Bruton's Tyrosine Kinase Inhibitor Ibrutinib Induces Impressive Responses in B-Cell Malignancies
    Wiestner, Adrian
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (01) : 128 - 130
12345